Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in Patients With Cirrhosis and Atrial Fibrillation

• DOI: 10.7326/m23-3067
• Publication Date: 2024-07-08T21:05:06Z
• Authors: Tracey G. Simon; Daniel E. Singer; Yichi Zhang; Julianna M. Mastr...; Alexander Cervone; Elyse DiCesare; Kueiyu Joshua Lin
• Keywords: Apixaban

Apixaban, rivaroxaban, and warfarin have shown benefit for preventing major ischemic events, albeit with increased bleeding risk, among patients in the general population atrial fibrillation (AF). However, data are scarce cirrhosis AF.